131 related articles for article (PubMed ID: 38627251)
1. Dihydrophenazine: a multifunctional new weapon that kills multidrug-resistant Acinetobacter baumannii and restores carbapenem and oxidative stress susceptibilities.
Mahdally NH; ElShiekh RA; Thissera B; Eltaher A; Osama A; Mokhtar M; Elhosseiny NM; Kashef MT; Magdeldin S; El Halawany AM; Rateb ME; Attia AS
J Appl Microbiol; 2024 May; 135(5):. PubMed ID: 38627251
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
3. Adaptations of carbapenem resistant
Sharma S; Das A; Banerjee T; Barman H; Yadav G; Kumar A
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33739918
[No Abstract] [Full Text] [Related]
4. Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt.
Jalal D; Elzayat MG; Diab AA; El-Shqanqery HE; Samir O; Bakry U; Hassan R; Elanany M; Shalaby L; Sayed AA
mSphere; 2021 Dec; 6(6):e0072521. PubMed ID: 34787450
[TBL] [Abstract][Full Text] [Related]
5. Enhancing effect of natural adjuvant, panduratin A, on antibacterial activity of colistin against multidrug-resistant Acinetobacter baumannii.
Thadtapong N; Chaturongakul S; Napaswad C; Dubbs P; Soodvilai S
Sci Rep; 2024 Apr; 14(1):9863. PubMed ID: 38684853
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial activity of exogenous glutathione and its synergism on antibiotics sensitize carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
Alharbe R; Almansour A; Kwon DH
Int J Med Microbiol; 2017 Oct; 307(7):409-414. PubMed ID: 28781060
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
[TBL] [Abstract][Full Text] [Related]
8. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M
Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896
[TBL] [Abstract][Full Text] [Related]
9.
Han R; Ding L; Yang Y; Guo Y; Yin D; Wu S; Zhi P; Zhu D; Liu Q; Tan X; Zhu Y; Zhang J; Li L; Hu F
Microbiol Spectr; 2022 Feb; 10(1):e0147121. PubMed ID: 35138143
[TBL] [Abstract][Full Text] [Related]
10. Systematic Review of Antimicrobial Resistance of Clinical Acinetobacter baumannii Isolates in Iran: An Update.
Razavi Nikoo H; Ardebili A; Mardaneh J
Microb Drug Resist; 2017 Sep; 23(6):744-756. PubMed ID: 28085571
[TBL] [Abstract][Full Text] [Related]
11. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR
J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance.
Ibrahim ME
Ann Clin Microbiol Antimicrob; 2019 Jan; 18(1):1. PubMed ID: 30606201
[TBL] [Abstract][Full Text] [Related]
13. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Effects of Inhibitor of
Na SH; Jeon H; Oh MH; Kim YJ; Chu M; Lee IY; Lee JC
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830146
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and Mechanisms of Carbapenem Resistance Among
Benmahmod AB; Said HS; Ibrahim RH
Microb Drug Resist; 2019 May; 25(4):480-488. PubMed ID: 30394846
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and molecular characterisations of carbapenem-resistant
Simo Tchuinte PL; Rabenandrasana MAN; Kowalewicz C; Andrianoelina VH; Rakotondrasoa A; Andrianirina ZZ; Enouf V; Ratsima EH; Randrianirina F; Collard JM
Antimicrob Resist Infect Control; 2019; 8():31. PubMed ID: 30792853
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Activity of a Repurposed Harmine-Derived Compound on Carbapenem-Resistant
Breine A; Van Gysel M; Elsocht M; Whiteway C; Philippe C; Quinet T; Valcek A; Wouters J; Ballet S; Van der Henst C
Front Cell Infect Microbiol; 2021; 11():789672. PubMed ID: 35141168
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infections.
Neshani A; Sedighian H; Mirhosseini SA; Ghazvini K; Zare H; Jahangiri A
Microb Pathog; 2020 Sep; 146():104238. PubMed ID: 32387392
[TBL] [Abstract][Full Text] [Related]
19. Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.
Viehman JA; Nguyen MH; Doi Y
Drugs; 2014 Aug; 74(12):1315-33. PubMed ID: 25091170
[TBL] [Abstract][Full Text] [Related]
20. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
